INMED PHARMACEUTICALS INC. Weighted Average Cost Inventory Amount
INMED PHARMACEUTICALS INC. (INM) had Weighted Average Cost Inventory Amount of $70.00 thousand as of 2025-12-31, per its 10-Q filed 2026-02-11.
Financial Statements › Notes › Inventory
us-gaap:WeightedAverageCostInventoryAmount · last filed 2026-02-11
- 2025-12-31: Weighted Average Cost Inventory Amount $70.00K.
- 2024-06-30: Weighted Average Cost Inventory Amount $103.43K.
- 2023-12-31: Weighted Average Cost Inventory Amount $357.22K.
- 2023-06-30: Weighted Average Cost Inventory Amount $93.82K.
| Period end | Weighted Average Cost Inventory Amount |
|---|---|
| 2025-12-31 | $70.00K 10-Q · filed 2026-02-11 |
| 2024-06-30 | $103.43K 10-K · filed 2024-09-30 |
| 2023-12-31 | $357.22K 10-Q · filed 2024-02-13 |
| 2023-06-30 | $93.82K 10-K · filed 2024-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |